These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10025401)

  • 1. Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter.
    Zheleznova EE; Markham PN; Neyfakh AA; Brennan RG
    Cell; 1999 Feb; 96(3):353-62. PubMed ID: 10025401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary structural studies on the multi-ligand-binding domain of the transcription activator, BmrR, from Bacillus subtilis.
    Zheleznova EE; Markham PN; Neyfakh AA; Brennan RG
    Protein Sci; 1997 Nov; 6(11):2465-8. PubMed ID: 9385651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of ligand recognition by BmrR, the multidrug-responding transcriptional regulator: mutational analysis of the ligand-binding site.
    Vázquez-Laslop N; Markham PN; Neyfakh AA
    Biochemistry; 1999 Dec; 38(51):16925-31. PubMed ID: 10606527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational plasticity of the coiled-coil domain of BmrR is required for bmr operator binding: the structure of unliganded BmrR.
    Kumaraswami M; Newberry KJ; Brennan RG
    J Mol Biol; 2010 Apr; 398(2):264-75. PubMed ID: 20230832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of BmrR-drug complexes reveal a rigid multidrug binding pocket and transcription activation through tyrosine expulsion.
    Newberry KJ; Huffman JL; Miller MC; Vazquez-Laslop N; Neyfakh AA; Brennan RG
    J Biol Chem; 2008 Sep; 283(39):26795-804. PubMed ID: 18658145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ostensible paradox of multidrug recognition.
    Neyfakh AA
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):151-4. PubMed ID: 11321567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates.
    Ahmed M; Borsch CM; Taylor SS; Vázquez-Laslop N; Neyfakh AA
    J Biol Chem; 1994 Nov; 269(45):28506-13. PubMed ID: 7961792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain.
    Markham PN; Ahmed M; Neyfakh AA
    J Bacteriol; 1996 Mar; 178(5):1473-5. PubMed ID: 8631728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the transcription activator BmrR bound to DNA and a drug.
    Heldwein EE; Brennan RG
    Nature; 2001 Jan; 409(6818):378-82. PubMed ID: 11201751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of multiple drugs by a single protein: a trivial solution of an old paradox.
    Vazquez-Laslop N; Zheleznova EE; Markham PN; Brennan RG; Neyfakh AA
    Biochem Soc Trans; 2000; 28(4):517-20. PubMed ID: 10961951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad ligand specificity of the transcriptional regulator of the Bacillus subtilis multidrug transporter Bmr.
    Markham PN; LoGuidice J; Neyfakh AA
    Biochem Biophys Res Commun; 1997 Oct; 239(1):269-72. PubMed ID: 9345308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structure-based mechanism for drug binding by multidrug transporters.
    Zheleznova EE; Markham P; Edgar R; Bibi E; Neyfakh AA; Brennan RG
    Trends Biochem Sci; 2000 Feb; 25(2):39-43. PubMed ID: 10664577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of MtaN, a global multidrug transporter gene activator.
    Godsey MH; Baranova NN; Neyfakh AA; Brennan RG
    J Biol Chem; 2001 Dec; 276(50):47178-84. PubMed ID: 11581256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural contributions to multidrug recognition in the multidrug resistance (MDR) gene regulator, BmrR.
    Bachas S; Eginton C; Gunio D; Wade H
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11046-51. PubMed ID: 21690368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated.
    Ahmed M; Lyass L; Markham PN; Taylor SS; Vázquez-Laslop N; Neyfakh AA
    J Bacteriol; 1995 Jul; 177(14):3904-10. PubMed ID: 7608059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mta, a global MerR-type regulator of the Bacillus subtilis multidrug-efflux transporters.
    Baranova NN; Danchin A; Neyfakh AA
    Mol Microbiol; 1999 Mar; 31(5):1549-59. PubMed ID: 10200972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconventional Coupling between Ligand Recognition and Allosteric Control in the Multidrug Resistance Gene Regulator, BmrR.
    Bachas S; Kohrs B; Wade H
    ChemMedChem; 2017 Mar; 12(6):426-430. PubMed ID: 28090749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural mechanism for transcription activation by MerR family member multidrug transporter activation, N terminus.
    Newberry KJ; Brennan RG
    J Biol Chem; 2004 May; 279(19):20356-62. PubMed ID: 14985361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural mechanisms of QacR induction and multidrug recognition.
    Schumacher MA; Miller MC; Grkovic S; Brown MH; Skurray RA; Brennan RG
    Science; 2001 Dec; 294(5549):2158-63. PubMed ID: 11739955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the Escherichia coli transcriptional activator MarA using alanine-scanning mutagenesis: residues important for DNA binding and activation.
    Gillette WK; Martin RG; Rosner JL
    J Mol Biol; 2000 Jun; 299(5):1245-55. PubMed ID: 10873449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.